Congress expands drug-detection mandate to counter emerging nitazene threat
S. 3093 — DETECT Nitazenes Act of 2025 · Filed by Eric Schmitt (R-MO) · 6 cosponsors · Introduced Nov 3, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Homeland Security's Science and Technology Directorate to work with the Drug Enforcement Agency to develop detection and identification technology for nitazenes—a synthetic opioid increasingly appearing in illicit drug supplies—at very low concentrations. It amends existing law to add nitazenes to the list of drugs the DHS is already tasked with detecting, alongside fentanyl and xylazine.
Why we flagged it
The bill is a straightforward expansion of existing DHS/DEA drug-detection authority to address an emerging public-health threat. It adds a newly prevalent illicit substance to an existing mandate without creating new restrictions, subsidies, or private carve-outs.
What the text implies
- Nitazenes are often mixed into heroin and counterfeit pills without user knowledge; enhanced detection may reduce accidental overdose deaths by enabling supply-chain intervention before distribution.
- The bill does not appropriate funds or specify implementation timelines, so effectiveness depends on DHS/DEA budget prioritization and technical feasibility of detecting nitazenes at 'very low concentrations'—a potentially challenging analytical threshold.
- Expanded detection capacity may increase law-enforcement interdiction activity, which could shift illicit-drug markets or supply routes but is unlikely to harm ordinary citizens.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill expands public-health and law-enforcement capacity to detect and disrupt a dangerous synthetic opioid that has emerged as a significant overdose risk. Citizens benefit from enhanced detection technology and supply-chain disruption without new restrictions on rights or remedies.
Who stands to gain
- analytical chemistry and detection-technology vendors (potential contractors to DHS/DEA for equipmen
Named in the bill
Department of Homeland Security, Science and Technology Directorate, Drug Enforcement Agency, Homeland Security Act of 2002, nitazenes, fentanyl, xylazine
Where it stands
6 cosponsors: 3 Democrats, 3 Republicans.
- Nov 3, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Nov 3, 2025 — Referred to Senate Committee on Homeland Security and Governmental Affairs · Congress.gov: “Read twice and referred to the Committee on Homeland Security and Governmental Affairs”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (435 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress expands drug-detection mandate to counter emerging nitazene threat” QuorumCivic. https://share.quorumcivic.app/bill/119/s3093 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.